CRBP - Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.